Memorial Sloan Kettering Cancer Center, 1275 York Avenue, C-886, New York, NY, 10065, USA.
Department of Medical Microbiology and Parasitology, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
World J Surg. 2019 Nov;43(11):2674-2680. doi: 10.1007/s00268-019-05100-0.
The fecal immunochemical test (FIT) for hemoglobin is recommended for colorectal cancer (CRC) screening in resource-limited environments. However, there are several unique variables that may alter FIT performance in this setting, including endemic intestinal parasites and high ambient temperature. This prospective study evaluated the performance of FIT in asymptomatic, average-risk individuals of screening age in rural Nigeria.
Three hundred and twenty-four community volunteers completed a questionnaire and provided stool specimens for parasitology and microbiome analysis. Specimens were frozen and stored at -80 °C. Of 324 subjects, 139 met criteria for average-risk CRC screening and had a stool sample for analysis. These were thawed and tested with a qualitative FIT. Specimens positive for occult blood were retested every two days to evaluate the impact of time and temperature on test performance.
Of 139 individuals, 69 (49.6%) were positive for intestinal parasites and 10 (7.2%) were positive for occult blood. The most common pathogen was Cryptosporidium (40.6%). Among patients with intestinal parasites, 10.1% (7/69) had a positive FIT. Only 4.3% (3/70) of patients without parasites had a positive FIT (p = 0.208). On bivariate analysis, sociodemographic variables were not associated with a positive FIT result. Thirty percent (3/10) of the FIT-positive specimens became FIT-negative with routine storage.
Although a positive FIT result was more common in those with parasitic infection, the relationship was not significant in this small cohort. The impact of high ambient temperature on test positivity may necessitate shorter processing time guidelines for equatorial countries. Additional prospective studies are needed to validate FIT performance in Nigeria.
粪便免疫化学检测(FIT)用于血红蛋白检测,推荐用于资源有限环境中的结直肠癌(CRC)筛查。然而,在这种环境下,有几个独特的变量可能会改变 FIT 的性能,包括地方性肠道寄生虫和高环境温度。本前瞻性研究评估了 FIT 在尼日利亚农村无症状、平均风险的筛查年龄人群中的表现。
324 名社区志愿者完成了一份问卷,并提供了粪便样本进行寄生虫学和微生物组分析。标本冷冻并储存在-80°C。在 324 名受试者中,有 139 名符合平均风险 CRC 筛查标准,并提供了粪便样本进行分析。这些样本解冻后用定性 FIT 进行检测。潜血阳性的标本每两天复测一次,以评估时间和温度对试验性能的影响。
在 139 名个体中,有 69 名(49.6%)存在肠道寄生虫感染,10 名(7.2%)存在潜血阳性。最常见的病原体是隐孢子虫(40.6%)。在有肠道寄生虫的患者中,有 10.1%(7/69)的 FIT 阳性。没有寄生虫的患者中只有 4.3%(3/70)的 FIT 阳性(p=0.208)。在单变量分析中,社会人口统计学变量与 FIT 阳性结果无关。30%(3/10)的 FIT 阳性标本在常规储存下变为 FIT 阴性。
尽管 FIT 阳性结果在寄生虫感染患者中更为常见,但在这个小队列中,这种关系并不显著。高环境温度对检测阳性率的影响可能需要为赤道国家制定更短的处理时间指南。需要进一步的前瞻性研究来验证 FIT 在尼日利亚的性能。